Treating myopic foveoschisis

Article

Treating myopic foveoschisis

Vitreous cortex removal and internal limiting membrane (ILM) peeling could be critical in treating persistent myopic foveoschisis (MF), according to the results of a study published in the American Journal of Ophthalmology.

Kaori Sayanagi, Yasushi Ikuno and Yasuo Tano from Osaka University Medical School, Osaka, Japan, examined two highly myopic eyes of two patients with persistent MF after primary vitrectomy and gas tamponade. Both were then treated with pars plana vitrectomy, residual vitreous cortex removal, ILM peeling and long-term gas tamponade.In both cases total foveal reattachment was achieved in addition to improvements in best-corrected visual acuity.

The authors concluded that re-operation with vitreous cortex removal and ILM peeling could benefit patients with MF after their primary surgery. It also indicates that both treatments, if used in the first instance, could prevent the need for any re-operation at all.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.